Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur L2-9786138395140
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur L2-9786138395140
Quantité disponible : Plus de 20 disponibles
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. N° de réf. du vendeur I-9786138395140
Quantité disponible : Plus de 20 disponibles
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 144 pp. Englisch. N° de réf. du vendeur 9786138395140
Quantité disponible : 2 disponible(s)
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. This book provides a comprehensive exploration of cutting-edge strategies in the diagnosis and treatment of HER2-positive brain metastases, a critical challenge in oncology. The book highlights the integration of molecular imaging, targeted drug delivery, nanomedicine, and personalized therapeutic approaches to improve patient survival and quality of life. It examines the biological mechanisms driving HER2 signaling in brain tumors, while emphasizing translational research and clinical applications of theranostic platforms. Multidisciplinary perspectives are presented, bridging oncology, radiology, pharmacology, and neurosurgery to create a cohesive understanding of precision theranostics. Designed for researchers, clinicians, and graduate students, the book serves as both a scientific reference and a practical guide to novel interventions that combine diagnostics with therapeutics. It underscores the potential of individualized medicine in overcoming therapeutic resistance and advancing the future of neuro-oncology. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9786138395140
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Advances in Precision Theranostics for HER2-Positive Brain Metastases | Hamed Aghazadeh (u. a.) | Taschenbuch | Englisch | 2025 | Scholars' Press | EAN 9786138395140 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu. N° de réf. du vendeur 134172171
Quantité disponible : 5 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book provides a comprehensive exploration of cutting-edge strategies in the diagnosis and treatment of HER2-positive brain metastases, a critical challenge in oncology. The book highlights the integration of molecular imaging, targeted drug delivery, nanomedicine, and personalized therapeutic approaches to improve patient survival and quality of life. It examines the biological mechanisms driving HER2 signaling in brain tumors, while emphasizing translational research and clinical applications of theranostic platforms. Multidisciplinary perspectives are presented, bridging oncology, radiology, pharmacology, and neurosurgery to create a cohesive understanding of precision theranostics. Designed for researchers, clinicians, and graduate students, the book serves as both a scientific reference and a practical guide to novel interventions that combine diagnostics with therapeutics. It underscores the potential of individualized medicine in overcoming therapeutic resistance and advancing the future of neuro-oncology.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 144 pp. Englisch. N° de réf. du vendeur 9786138395140
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This book provides a comprehensive exploration of cutting-edge strategies in the diagnosis and treatment of HER2-positive brain metastases, a critical challenge in oncology. The book highlights the integration of molecular imaging, targeted drug delivery, nanomedicine, and personalized therapeutic approaches to improve patient survival and quality of life. It examines the biological mechanisms driving HER2 signaling in brain tumors, while emphasizing translational research and clinical applications of theranostic platforms. Multidisciplinary perspectives are presented, bridging oncology, radiology, pharmacology, and neurosurgery to create a cohesive understanding of precision theranostics. Designed for researchers, clinicians, and graduate students, the book serves as both a scientific reference and a practical guide to novel interventions that combine diagnostics with therapeutics. It underscores the potential of individualized medicine in overcoming therapeutic resistance and advancing the future of neuro-oncology. N° de réf. du vendeur 9786138395140
Quantité disponible : 2 disponible(s)
Vendeur : Books Puddle, New York, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26405273190
Quantité disponible : 4 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand. N° de réf. du vendeur 407913913
Quantité disponible : 4 disponible(s)